PR Newswire Automotive#pr
ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trialtranslating…
1h agoFactuality: 77/100UnknownPR Press Ltd
SHANGHAI, Aug. 14, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has approved ziresovir (AK0529) for a phase II clinical trial in the severely ill RSV infected infant patients, including…